-
Common cold coronaviruses hinder antibody immune response to SARS-CoV-2 infection
01/12/2022
St. Jude study also suggests that prior immunity to common cold coronaviruses does not protect against SARS-CoV-2 infection.
-
Modular super-enhancer controls retinal development
01/11/2022
Scientists at St. Jude identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer.
-
Understanding how autoactivation triggers cell death
01/11/2022
Scientists from St. Jude have captured the structure of autoactivated BAK, a key protein for triggering apoptosis in cancer cells.
-
Secrets of regulatory T cell development reveal clinical possibilities
12/29/2021
St. Jude scientists have identified key steps in production of the regulatory T cells that have a role in everything from autoimmune disorders to cancer.
-
SARS-CoV-2 vaccination creates a strong, persistent T-cell response
12/23/2021
St. Jude Immunology study details how T cells respond to mRNA vaccination for SARS-CoV-2. Published in Cell, in collaboration with Washington University St. Louis.
-
DrLupo surpasses $10 million in lifetime fundraising for St. Jude Children’s Research Hospital in 24-hour Build Against Cancer livestream
12/20/2021
Spanning four years of support, YouTube Gaming creator and dedicated St. Jude supporter DrLupo passes $10 million in cumulative fundraising for St. Jude.
-
Research reveals features that influence phase separation
12/20/2021
St. Jude researchers reveal more details of processes cells use to organize the proteins within them, which may provide insight into neurological diseases and cancer.
-
Chromatin architecture reveals vulnerabilities to neurodegenerative movement disorders
12/15/2021
St. Jude researchers showed why neurons called Purkinje cells in the cerebellum are particularly susceptible to DNA damage that goes unrepaired.
-
Phase separation underlies leukemia caused by NUP98 fusion oncoproteins
12/13/2021
St. Jude scientists describe how a group of well-known fusion oncoproteins causes leukemia in the journal Cancer Discovery.
-
World Health Organization and St. Jude Children’s Research Hospital to dramatically increase global access to childhood cancer medicines
12/13/2021
WHO and St. Jude will establish a platform to dramatically increase access to childhood cancer medicines in low- and middle-income countries
-
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
12/06/2021
St. Jude phase II clinical trial results suggest monoclonal antibody hu14.18K322A could help change treatment of children with high-risk neuroblastoma.
-
St. Jude at ASH: Annual hematology meeting highlights recent research
12/06/2021
Researchers will present their work and share their expertise at ASH2021, the 63rd annual meeting of the American Society of Hematology.
-
20,000 runners lace up shoes for 20th St. Jude Memphis Marathon Weekend
12/03/2021
17,000 in-person and 3,000 virtual runners will unite to raise more than $12 million for the kids of St. Jude.
-
WMC anchor Joe Birch named St. Jude Hero Among Us in recognition of 20 years running, fundraising for St. Jude Children’s Research Hospital
12/03/2021
The Hero Among Us award is given each year during Memphis Marathon® Weekend to a St. Jude Hero who exemplifies what it means to participate with purpose for the kids of St. Jude.
-
Exhaustion affects CAR T–cell clinical response
11/30/2021
Clinical trial data reveals what controls the staying power of T cells, affecting immunotherapy responses. St. Jude scientists' findings were published in Cell Reports.
-
Shift4Shop announces partnership with St. Jude Children’s Research Hospital to facilitate e-commerce donations for research, treatment of childhood cancer
11/29/2021
Online merchants utilizing Shift4Shop’s turnkey e-commerce platform can help their customers’ donate to St. Jude after completing their purchases.
-
Findings reveal new mechanism of activation for ALK
11/24/2021
St. Jude Children’s Research Hospital scientists have shed light on the way ligands bind to and activate ALK, an important target for cancer drug development.
-
Discovery of how immune cells sense nutrients offers new therapeutic insight
11/18/2021
St. Jude scientists map nutrient-dependent signaling in T cells, offering possible new drug targets for treating infectious diseases, cancer and immune-mediated disorders.
-
Country music industry leaders Lon Helton, Bill Mayne recognized by St. Jude Children’s Research Hospital with Randy Owen Angels Among Us Award
11/17/2021
The award is presented by Alabama singer and co-founder of Country Cares, Randy Owen, who started the award to recognize others showing his dedication to the mission of St. Jude.
-
Target prevents T-cell exhaustion, boosts CAR T–cell responses
11/17/2021
Findings from St. Jude Children’s Research Hospital show how epigenetic regulation by the enzyme DNMT3A controls T-cell exhaustion providing a target for improving CAR T–cell immunotherapy.
-
St. Jude researchers are again among the world’s most highly cited scientists
11/16/2021
The fourteen scientists are among the most highly cited investigators in the world during the past decade, reflecting the international reach of St. Jude research.
-
St. Jude supporters to strike a joyful chord in Music City for annual St. Jude Rock ‘n’ Roll Running Series Nashville
11/10/2021
Fitness and music merge to benefit the lifesaving mission of St. Jude.
-
St. Jude Children’s Research Hospital embarks on next era of scientific discovery with Inspiration4 Advanced Research Center
11/09/2021
New research center named for historic space mission led by Jared Isaacman supports overarching $11.5 billion, six-year St. Jude strategic expansion plan.
-
Safety concerns raised for neuroblastoma candidate drug
11/09/2021
St. Jude Children’s Research Hospital scientists have identified the primary target of the experimental cancer drug CX-5164, revealing a possible risk for late effects of treatment.
-
Help DrLupo surpass $10 million lifetime fundraising milestone during 4th annual Build Against Cancer 24-hour livestream
11/08/2021
YouTube Gaming event on Dec. 18 set to break record for most money raised by a single content creator benefiting St. Jude Children’s Research Hospital.
-
Together by St. Jude Teaches Children about the COVID-19 Vaccines in New Coloring Book
11/02/2021
Following FDA authorization of the COVID-19 vaccine for children ages 5 to 11, St. Jude releases a free coloring book that educates children on vaccines.
-
St. Jude Children’s Research Hospital celebrates Diwali with GYFTING
11/01/2021
Proceeds from limited edition Diwali gift box featuring products from South Asian-led businesses will support St. Jude research, treatment into childhood cancer, life-threatening diseases.
-
Inspiration4 auction for St. Jude Children's Research Hospital to include one-of-a-kind payload items that orbited Earth
11/01/2021
The first all-civilian mission to orbit the Earth last September included special cargo for a post-splashdown auction, benefiting St. Jude Children's Research Hospital.
-
St. Jude Heroes reach $100 million milestone for St. Jude Memphis Marathon® Weekend
11/01/2021
Fitness enthusiasts have raised more than $100 million for St. Jude Children’s Research Hospital as charity-run event celebrates its 20th anniversary.
-
Rich Eisen receives St. Jude Ambassador of the Year award in recognition of his dedication to St. Jude Children’s Research Hospital
10/25/2021
What began in 2005 as a fun 40-yard-dash by NFL broadcaster Rich Eisen has since become the philanthropic phenomenon known as Run Rich Run, now entering its seventh year as a fundraiser benefiting St. Jude.
